Brief: Erytech Pharma March-End Cash And Cash Equivalents Of EUR 37.4 Millions

Phaxiam Therapeutics SA

29/04/2021 06:51

April 29 (Reuters) - ERYTECH PHARMA  ERYP.PA :
    * REPORTS CASH BALANCE AT END OF Q1 2021 
    * CASH AND CASH EQUIVALENTS TOTALLING €37.4 MILLION
(APPROXIMATELY
$43.9 MILLION), COMPARED WITH €44.4 MILLION ON DECEMBER 31, 2020
    * SAYS CURRENT CASH POSITION CAN FUND ITS PLANNED OPERATING
EXPENSES AND CURRENT PROGRAMS INTO Q4 2021 AND INTO Q1 2022

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE6TTg0v
    
 Further company coverage:  ERYP.PA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))